Asia Pacific Pharmaceutical contract manufacturing market | Industry ? Size, Share, Growth, Forecasts | Asia Pacific Solid Dosage form market | Asia Pacific Liquid Dosage form market | Asia Pacific Injectable dosage form market
Asia-Pacific Pharmaceutical Contract Manufacturing Market  - By Type (Active Pharmaceutical Ingredient manufacturing, Finished Dosage Formulation Development and Manufacturing, Secondary Market), Country, Trends, Forecasts - (2017 - 2022)

PUBLISHED

DEC 2017

Asia-Pacific Pharmaceutical Contract Manufacturing Market - By Type (Active Pharmaceutical Ingredient manufacturing, Finished Dosage Formulation Development and Manufacturing, Secondary Market), Country, Trends, Forecasts - (2017 - 2022)

Purchase Report

The APAC pharmaceutical contract manufacturing market was worth USD XX.XX billion in 2017 and is projected to reach USD XX.XX billion by 2022, at a CAGR of XX.XX%. Active Pharmaceutical Ingredient (API) holds the highest market share, while final dosage form is estimated to be the top growing segment during the forecasted period. The companies in the upstream industry are undergoing restructuring so as to focus more on R&D. Added to this, stringent regulations on the pharmaceutical industry are compelling the companies to outsource the manufacturing of drugs.

Contract manufacturing involves the outsourcing of manufacturing of the products to third party vendors. Pharmaceutical contract manufacturers are then given the chemical formulation of the drug from the pharmaceutical company and then prepare/manufacture in their location. The contract manufacturing market is growing significantly since the pharmaceutical companies are focusing more on R&D of the drugs instead of manufacturing the formulated drug to stay competitive in the market.

Pharmaceutical companies are going for fewer vendors to take volume advantage and at the same time reduce logistics costs. The growing number of innovative drugs is driving the market, while in-house manufacturing is a chief constraint. The final dosage form manufacturing is a major opportunity in this sector.

The market is segmented on the basis of dosage formulation and country. Based on dosage formulation, the contract manufacturing market can be segmented into solid dosage formulation, liquid dosage formulation, and injectable dosage formulation.

Some of the key players in the market are:

  • Aenova
  • Baxter BioPharma Solutions
  • Catalent
  • Famar
  • Haupt Pharma
  • Jubilant
  • Pfizer CentreSource
  • Recipharm
  • Vetter

What the Report Offers

  • Market definition along with identification of key drivers and restraints for the market.
  • Market analysis with region-specific assessments and competition analysis on a global and regional scale.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
  • Identification and analysis of the macro and micro factors that affect the industry on both global and regional scale.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

1. Research Methodology

2. Executive Summary

3. Market Overview

            3.1 Overview

            3.2 Industry Value Chain Analysis

            3.3 Industry Attractiveness - Porter's 5 Force Analysis

                        3.3.1 Bargaining Power of Suppliers

                        3.3.2 Bargaining Power of Consumers

                        3.3.3 Threat from New Entrants

                        3.3.4 Threat from Substitute Products

                        3.3.5 Competitive Rivalry within the Industry

            3.4 Industry Policies

4. Market Dynamics

            4.1 Introduction

            4.2 Drivers

                        4.2.1 Growing Innovative drugs

            4.3 Restraints

                        4.3.1 In-house manufacturing

            4.4 Opportunities

                        4.4.1 Final dosage form manufacturing

5. Pharmaceutical Contract Manufacturing Market Segmentation, Forecasts, and Trends - by Revenue

            5.1 By Dose Formulation Type

                        5.1.1 Solid Dose Formulation

                        5.1.2 Liquid Dose Formulation

                        5.1.3 Injectable Dose Formulation

            5.2 By Country

                        5.2.1 China

                        5.2.2 India

                        5.2.3 Japan

                        5.2.4 Australia

                        5.2.5 Others

6. APAC Vendor Market Share Analysis

7. Competitive Intelligence - Company Profiles

            7.1 Famar

            7.2 Recipharm

            7.3 Jubilant

            7.4 Vetter

            7.5 Pfizer CentreSource

            7.6 Aenova

            7.7 Catalent

            7.8 Haupt Pharma

            7.9 Baxter Bio Pharma Solutions

8. Investment Analysis

            8.1 Recent Mergers and Acquisitions

            8.2 Investment Scenario and Opportunities

9. Future of Pharmaceutical Contract Manufacturing Market

LIST OF TABLES

1: APAC Pharmaceutical Contract Manufacturing market Revenue, 2014-2020 (USD Billion)

2: Pharmaceutical Contract Manufacturing market Revenue, by Dose Formulation Type, Solid Dose Formulation, 2014-2020 (USD Billion)

3: Pharmaceutical Contract Manufacturing market Revenue, by Dose Formulation Type, Liquid Dose Formulation, 2014-2020 (USD Billion)

4: Pharmaceutical Contract Manufacturing market Revenue, by Dose Formulation Type, Injectable Dose Formulation, 2014-2020 (USD Billion)

5: Pharmaceutical Contract Manufacturing market Revenue, by Region, Asia-Pacific, 2014-2020 (USD Billion)

6: Pharmaceutical Contract Manufacturing market Revenue, by Country, China, 2014-2020 (USD Billion)

7: Pharmaceutical Contract Manufacturing market Revenue, by Country, Japan, 2014-2020 (USD Million)

8: Pharmaceutical Contract Manufacturing market Revenue, by Country, India, 2014-2020 (USD Million)

9: Pharmaceutical Contract Manufacturing market Revenue, by Country, Australia, 2014-2020 (USD Million)

10: Pharmaceutical Contract Manufacturing market Revenue, by Country, Others, 2014-2020 (USD Million)

Purchase Report

Our Clients Include View All

Looking to Customize Report?